Axalta Coating Systems
AXTA
$28.55
+5.12%
Axalta Coating Systems Ltd. is a global manufacturer, marketer, and distributor of high-performance coatings systems, operating within the specialty chemicals industry. The company is a significant player in the coatings market, distinct for its dual-segment focus on Performance Coatings for refinish and industrial applications and Mobility Coatings for original equipment manufacturers (OEMs) of vehicles. The current investor narrative is shaped by the stock's significant underperformance relative to the broader market over the past year, raising questions about its cyclical exposure to the automotive and industrial sectors, its ability to navigate input cost pressures, and its potential for margin recovery and growth acceleration amidst a challenging macroeconomic backdrop.…
AXTA
Axalta Coating Systems
$28.55
Investment Opinion: Should I buy AXTA Today?
Rating & Thesis: Hold. AXTA presents a high-risk, high-potential-reward situation where the compelling forward valuation is counterbalanced by significant cyclical and financial risks, warranting a cautious stance pending clearer signs of an earnings turnaround.
Supporting Evidence: The forward P/E of 10.68x is the primary attraction, suggesting deep value if the $3.35 EPS target is hit. The stock trades at reasonable absolute multiples with a P/S of 1.36x and EV/Sales of 1.73x. Profitability metrics like a 14.36% operating margin and 16.11% ROE are solid. However, these positives are offset by a -38.84% one-year relative strength, a high debt-to-equity ratio of 1.45, and a volatile beta of 1.33.
Risks & Conditions: The two biggest risks are a failure to achieve the projected earnings recovery and a deterioration in its cyclical end-markets. This Hold rating would upgrade to a Buy if the stock demonstrates sustained quarterly earnings progress toward the $3.35 target and holds above the $24.94 support on a retest. It would downgrade to a Sell if forward EPS estimates are materially cut or if the debt-to-equity ratio increases further. Based on the available data, the stock appears fairly valued for its risk profile, neither clearly overvalued nor undervalued.
Sign up to view all
AXTA 12-Month Price Forecast
The outlook for AXTA is bifurcated and highly dependent on the execution of its earnings recovery plan. The base case of modest progress and range-bound trading is most probable, given the cyclical challenges. The bull case, while offering significant upside, requires a flawless operational performance in a difficult environment. The stance is neutral due to the high degree of binary risk; confidence is medium as key data on peer valuation and quarterly revenue trends is missing. The stance would upgrade to bullish on confirmation of margin expansion and debt reduction, or downgrade to bearish on a breakdown below the $24.94 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axalta Coating Systems's 12-month outlook, with a consensus price target around $37.12 and implied upside of +30.0% versus the current price.
Average Target
$37.12
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$23 - $37
Analyst target range
Analyst coverage for Axalta is limited, with only 5 analysts providing estimates, which is typical for a mid-cap industrial name and can lead to higher volatility and less efficient price discovery. The consensus focuses on forward estimates, projecting an average EPS of $3.35 on revenue of $5.39 billion for the coming year, with a relatively tight range between low estimates of $3.30 and high estimates of $3.43 for EPS. The absence of a published consensus price target, buy/hold/sell distribution, or target price range in the provided data significantly limits the sentiment analysis. The implication of limited coverage and missing target data is that investor conviction may be lower, and the stock may be more susceptible to sharp moves on company-specific news or macroeconomic shifts, requiring investors to conduct deeper independent fundamental research.
Bulls vs Bears: AXTA Investment Factors
The evidence currently tilts bearish, as the stock's severe underperformance, high leverage, and volatile profile reflect deep-seated market skepticism about its cyclical business model. However, the bull case is anchored in a compelling forward valuation and analyst expectations for a dramatic earnings recovery. The single most important tension in the investment debate is whether the company can achieve the projected forward EPS of $3.35 to justify its current price, or if cyclical headwinds and cost pressures will persist, trapping the stock in its downtrend. The resolution of this earnings inflection will determine the direction of the stock.
Bullish
- Deep Value Forward P/E: The stock trades at a forward P/E of 10.68x based on analyst consensus EPS of $3.35, representing a significant discount to its trailing P/E of 18.46x. This implies the market is pricing in a substantial earnings recovery, which, if achieved, offers compelling valuation upside.
- Strong Recent Momentum Rebound: The stock has gained 10.54% over the past month, significantly outperforming the S&P 500's 7.36% gain. This suggests a potential shift in sentiment and a technical mean reversion attempt after a severe -38.84% relative underperformance over the past year.
- Respectable Profitability Metrics: Axalta maintains solid core profitability with an operating margin of 14.36% and a Return on Equity of 16.11%. The ROE, while boosted by leverage, indicates efficient use of shareholder capital, and the gross margin of 32.52% provides a reasonable base for earnings expansion.
- Analyst EPS Growth Expectations: Analysts project forward EPS of $3.35, which is dramatically higher than the trailing EPS of $0.054. This consensus for a massive earnings inflection is the central pillar of the bull case, suggesting the company can overcome recent cyclical and cost pressures.
Bearish
- Severe Cyclical Underperformance: AXTA has declined 3.94% over the past year while the S&P 500 gained 34.9%, resulting in a staggering -38.84% relative strength. This underperformance highlights the market's deep concerns over its exposure to cyclical automotive and industrial end-markets.
- Elevated Financial Leverage: The company carries a high debt-to-equity ratio of 1.45, indicating significant financial risk. In a higher interest rate environment, this leverage pressures earnings, limits strategic flexibility, and increases vulnerability during an economic downturn.
- High Volatility and Drawdown Risk: With a beta of 1.33 and a recent maximum drawdown of -28.48%, the stock is 33% more volatile than the market and prone to sharp declines. This high-risk profile is confirmed by its recent plunge to near its 52-week low of $24.94.
- Limited Analyst Coverage & Conviction: Only 5 analysts cover the stock, and no consensus price target is available in the provided data. This limited coverage suggests lower institutional interest and can lead to less efficient price discovery, making the stock more susceptible to sharp moves on company-specific news.
AXTA Technical Analysis
The stock is in a pronounced downtrend, having declined 3.94% over the past year, which starkly contrasts with the S&P 500's 34.9% gain, resulting in a severe -38.84% relative strength. As of the latest close at $30.00, the price is trading at approximately 28% of its 52-week range ($24.94 to $35.72), positioning it much closer to its 52-week low, which suggests either a deep value opportunity or a continued fundamental deterioration that the market is pricing in. Recent momentum shows a sharp divergence, with a strong 10.54% gain over the past month potentially signaling a short-term rebound or mean reversion attempt, yet this is against a backdrop of a -10.63% loss over the prior three months, indicating the recent uptick follows a period of significant weakness and its sustainability is uncertain. Key technical support is clearly defined at the 52-week low of $24.94, while immediate resistance lies at the recent high of $35.72. A decisive breakout above the $35.72 resistance would signal a potential trend reversal and a shift in market sentiment, whereas a breakdown below the $24.94 support could trigger a new leg down in the downtrend. The stock's beta of 1.33 indicates it is 33% more volatile than the market, which, combined with a maximum drawdown of -28.48% over the provided period, underscores its higher risk profile and the importance of position sizing for investors considering this name.
Beta
1.25
1.25x market volatility
Max Drawdown
-28.5%
Largest decline past year
52-Week Range
$25-$36
Price range past year
Annual Return
-14.2%
Cumulative gain past year
| Period | AXTA Return | S&P 500 |
|---|---|---|
| 1m | +8.2% | +11.4% |
| 3m | -15.5% | +8.3% |
| 6m | -1.5% | +9.4% |
| 1y | -14.2% | +31.3% |
| ytd | -13.5% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXTA Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data; however, analyst estimates point to expected annual revenue of approximately $5.39 billion, suggesting the market is modeling a stable top-line outlook. The company's profitability is modest, with a trailing net margin of 7.39% and a gross margin of 32.52%, indicating it converts a reasonable portion of sales to gross profit but faces significant operating expenses. The operating margin of 14.36% provides a clearer view of core profitability, though the absence of sequential quarterly margin data limits the analysis of expansion or compression trends. The balance sheet shows a leveraged position with a debt-to-equity ratio of 1.45, which is elevated and indicates a reliance on debt financing, increasing financial risk especially in a higher interest rate environment. Liquidity appears adequate with a current ratio of 2.06, suggesting the company can comfortably meet its short-term obligations. Return metrics are mixed, with a Return on Equity (ROE) of 16.11% that is respectable and potentially boosted by financial leverage, but a Return on Assets (ROA) of 6.55% is more modest, reflecting the efficiency of its total asset base.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXTA Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E stands at 18.46x, while the forward P/E is significantly lower at 10.68x, implying the market expects a substantial earnings recovery or growth, as the forward estimate of $3.35 EPS is far above the most recent trailing EPS figure of $0.054. Compared to sector averages, the valuation context is unclear as specific industry multiple data was not provided in the inputs. A standalone analysis shows the stock trades at a Price-to-Sales (P/S) ratio of 1.36x and an EV/Sales of 1.73x, which appear reasonable for a capital-intensive industrial business, but without peer benchmarks, it's difficult to classify it as a premium or discount. The negative PEG ratio of -10.95, driven by the low trailing EPS, is not a reliable signal and further highlights the market's focus on forward earnings expectations. Historical context for the valuation is also unavailable due to missing historical ratios data. Therefore, we cannot determine if the current P/E of 18.46x is near the top or bottom of its own historical range, which limits the assessment of whether the stock is priced for optimistic expectations or presents a value opportunity based on its own trading history.
PE
18.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Axalta's primary financial risk stems from its elevated leverage, with a debt-to-equity ratio of 1.45. This increases interest expense burdens and reduces financial resilience. While liquidity is adequate with a current ratio of 2.06, the modest net margin of 7.39% and gross margin of 32.52% leave limited buffer against raw material cost inflation. The company's valuation is entirely dependent on achieving a massive earnings leap to a forward EPS of $3.35; failure to meet this growth expectation would cause significant multiple compression.
Market & Competitive Risks: The stock's high beta of 1.33 makes it highly sensitive to broader market downturns and sector rotations away from cyclical industrials. Trading near its 52-week low, it faces valuation compression risk if the macroeconomic backdrop for automotive and industrial production weakens further. As a coatings manufacturer, it is exposed to competitive pressures from larger players and potential regulatory changes affecting chemical use. The lack of a clear valuation premium or discount to peers (due to missing data) adds uncertainty regarding its competitive positioning.
Worst-Case Scenario: The worst-case scenario involves a prolonged downturn in global automotive production and industrial activity, coupled with sustained high input costs. This would cause Axalta to miss its forward EPS targets significantly, leading to a re-rating from its forward P/E of 10.68x to a distressed multiple. A breakdown below the key technical support at the 52-week low of $24.94 could trigger accelerated selling. From the current price of $30.00, this scenario implies a realistic downside of approximately -17% to that support level, with potential for further declines if fundamentals deteriorate more severely.
FAQ
The key risks are, in order of severity: 1) Execution Risk: Failure to achieve the projected forward EPS of $3.35, which the entire valuation rests upon. 2) Cyclical Risk: Exposure to downturns in the automotive and industrial sectors, as evidenced by its severe market underperformance. 3) Financial Risk: Elevated debt-to-equity ratio of 1.45, which increases interest burden and default risk in a downturn. 4) Volatility Risk: A beta of 1.33 means the stock is likely to fall more than the market during corrections, as shown by its -28.48% max drawdown.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $30 and $33 as it makes gradual progress on earnings. The Bull Case (30% probability) targets a range of $35.72 to $38, driven by a successful earnings recovery to $3.35+ EPS. The Bear Case (20% probability) warns of a drop to the $24.94 - $28 range if cyclical pressures intensify and earnings disappoint. The Base Case is most likely, assuming the company meets lowered expectations but fails to spark a major re-rating.
Based on forward earnings, AXTA appears deeply undervalued with a P/E of 10.68x. However, this valuation is entirely contingent on achieving a massive earnings recovery to $3.35 EPS from a trailing base of $0.054. On absolute measures like P/S (1.36x) and EV/Sales (1.73x), it seems reasonably priced for an industrial business. Without peer comparison data, it's difficult to definitively call it over or undervalued. The market is currently valuing it at a discount that prices in significant execution risk and cyclical uncertainty.
AXTA is a high-risk, high-potential-reward stock that may be a good buy only for investors with a high risk tolerance and a conviction in a cyclical recovery. The forward P/E of 10.68x offers compelling value if the company hits its $3.35 EPS target. However, the severe -38.84% underperformance over the past year, high debt load (D/E of 1.45), and volatile beta of 1.33 present significant downside risks. It is not a good buy for conservative or income-seeking investors.
AXTA is not suitable for short-term trading due to its high volatility (beta 1.33) and lack of near-term catalysts beyond earnings reports. It is a speculative long-term investment for investors betting on a multi-year cyclical recovery and successful corporate turnaround. The investment thesis requires several quarters to play out as the company works toward its forward EPS targets. A minimum holding period of 2-3 years is suggested to weather volatility and allow the recovery narrative to unfold, though this comes with high risk.